Industry

WATERTOWN, Mass.–(BUSINESS WIRE)–Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections and liver diseases, today announced that data from Enanta’s internal development program portfolio for hepatitis B virus (HBV) and its out-licensing program portfolio for non-alcoholic steatohepatitis (NASH) have been accepted for poster presentations at the European … [Read more…]

Leading healthcare solutions company launches pharmacy with medication delivery, thereby extending its care-in-the-home approach to include diagnostic testing, virtual consultations, and treatment NEW YORK–(BUSINESS WIRE)–LetsGetChecked, a leading healthcare solutions company, announced today the launch of its pharmacy and medication delivery offering, pioneering a full lifecycle of personalized 360-degree healthcare from home. The offering adds to … [Read more…]

Phase 2a results show the orally administered ABP-671 significantly reduced uric acid levels without adverse side effects of existing drugs JIANGSU, China–(BUSINESS WIRE)–Atom Bioscience, a clinical stage biotechnology company developing new treatments for inflammatory and metabolic diseases, announced today it will update its clinical development of ABP-671, the company’s new oral drug for chronic gout, … [Read more…]

FORT WORTH, Texas–(BUSINESS WIRE)–Galderma, the leading company solely dedicated to advancing the future of dermatology, announced it will present four scientific presentations at the 2022 Vegas Cosmetic Surgery (VCS) & Aesthetic Dermatology Annual Symposium to showcase the latest advancements surrounding its approved and investigational product updates. “We look forward to unveiling the latest data and … [Read more…]

StatLab expands global reach and core manufacturing capabilities with CellPath Ltd. acquisition MCKINNEY, Texas–(BUSINESS WIRE)–StatLab Medical Products (StatLab), an Audax Private Equity and Linden Capital Partners portfolio company and a leading developer and manufacturer of medical diagnostic supplies and equipment, today announced that it has acquired CellPath Ltd. (CellPath), a UK-based manufacturer and supplier of … [Read more…]

BASINGSTOKE, England–(BUSINESS WIRE)–It is with great pleasure that Juniper Research announces the 2022 winners of the Future Digital Awards for Digital Health Innovation. This year’s awards received a record number of applications; making choosing winners more difficult than ever. These awards recognise the most innovative and impactful digital health solutions operating across numerous areas, including … [Read more…]

BOSTON & TORONTO–(BUSINESS WIRE)–Exchange Solutions, a personalized loyalty solutions provider, and Rexall Pharmacy Group have enhanced their loyalty management partnership by launching new loyalty program functionality for Be Well™ members. Automated, personalized offers for members will be distributed through the existing offer gallery available in the Be Well app and online profile, powered by Exchange … [Read more…]

Wellcome Centre for Cell-Matrix Research is funding a nanobody screening project leveraging Carterra’s platform MANCHESTER, England & SALT LAKE CITY–(BUSINESS WIRE)–The University of Manchester, United Kingdom, and Carterra, Inc., the world leader in innovative technologies enabling high-throughput biology, announced today that the University of Manchester has added Carterra’s LSA instrument to its Biomolecular Analysis Core … [Read more…]

SHANGHAI & SUZHOU, China–(BUSINESS WIRE)–EpimAb Biotherapeutics, a clinical-stage biotechnology company specializing in bispecific antibody development, today announced that the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) application for a Phase Ib/II study in patients with non-small cell lung cancer (NSCLC) evaluating the combination of EMB-01, a bispecific antibody designed … [Read more…]

WASHINGTON–(BUSINESS WIRE)–AIDS Healthcare Foundation (AHF) welcomes the U.S. Federal Trade Commission (FTC) announcement today that it will launch an inquiry into the practices of prescription drug middlemen and their questionable conduct. “Thank you, FTC, for hearing the voices of tens of thousands of pharmacies and patients across the country and launching an inquiry into the … [Read more…]